Biotech

All Articles

Analysts explore Avidity's DMD gain, showing subtleties in information

.Avidity Biosciences pleased clients along with phase 1/2 information in Duchenne muscle dystrophy (...

Actinogen's cortisol blocker falls short stage 2 clinical depression research study

.Actinogen Medical's cortisol blocker has missed the primary endpoint of a period 2 research study i...

Bivictrix determines going personal only technique to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually been at the center of several a billion-dollar biobuc...

TPG leadings up funds to $580M for expenditures around lifestyle sciences

.Resource manager TPG, which has supported biotechs including Sionna Therapeutics and also Santa Ana...

Merck stops phase 3 TIGIT test in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually endured another trouble. Months after shuttering a stage...

After a challenging year, Exscientia folds up in to Recursion

.After a year defined through pipe cuts, the departure of its own CEO and also layoffs, Exscientia w...

Cullinan, after $25M bargain, return bispecific to Harbour

.Cullinan Therapeutics was wowed good enough along with Harbour BioMed's bispecific invulnerable rea...

A better consider Ferocious Biotech's Strong 15

.In this particular week's episode of "The Leading Pipe," we're diving right into Tough Biotech's an...

Lilly deals with stage 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's event commemorating the approval of Alzheime...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant management hirings, firings ...